Defining Alzheimer’s Disease and MCI Management in the Modern Era

In this episode, Drs. Sabbagh and Isaacson discuss how to best approach Alzheimer’s disease (AD) and mild cognitive impairment (MCI) in clinical practice, including accurately diagnosing patients and optimizing treatment in terms of patient preferences and reimbursement options. The full episode covers:

• Defining AD and MCI and their clinical presentation
• How to diagnose AD vs MCI
• Reimbursement landscape for current diagnosing and monitoring tools
• Precision medicine’s evolving role in diagnosing and treating patients with AD and/or MCI

Presenters:

Marwan Sabbagh, MDProfessor of NeurologyAlzheimer’s and Memory Disorders DivisionDepartment of NeurologyBarrow Neurological InstitutePhoenix, Arizona

Richard Isaacson MDDirector of the Institute for Neurodegenerative DiseasesFlorida